Annals of Behavioral Medicine

, Volume 44, Issue 2, pp 207–215 | Cite as

Multisystemic Therapy Compared to Telephone Support for Youth with Poorly Controlled Diabetes: Findings from a Randomized Controlled Trial

  • Deborah A. Ellis
  • Sylvie Naar-King
  • Xinguang Chen
  • Kathleen Moltz
  • Phillippe B. Cunningham
  • April Idalski-Carcone
Original Article

Abstract

Background

Few interventions have effectively improved health outcomes among youth with diabetes in chronic poor metabolic control.

Purpose

This study aims to determine whether multisystemic therapy (MST), an intensive, home-based, tailored family treatment, was superior to weekly telephone support for improving regimen adherence and metabolic control among adolescents with chronic poor metabolic control.

Methods

A randomized controlled trial was conducted with 146 adolescents with types 1 or 2 diabetes. Data were collected at baseline, 7 months (treatment termination), and 12 months (6 months follow-up).

Results

Adolescents receiving MST had significantly improved metabolic control at 7 (1.01 % decrease) and 12 months (0.74 % decrease) compared to adolescents in telephone support. Parents of adolescents receiving MST reported significant improvements in adolescent adherence. However, adolescent-reported adherence was unchanged.

Conclusions

MST improved health outcomes among adolescents with chronic poor metabolic control when compared to telephone support. Home-based approaches may provide a viable means to improve access to behavioral interventions for such youth.

Keywords

Adherence Youth Diabetes Family treatment 

References

  1. 1.
    Burdick J, Chase HP, Slover RH, et al. Missed insulin meal boluses and elevated hemoglobin A1c levels in children receiving insulin pump therapy. Pediatrics. 2004; 113: e221–224.PubMedCrossRefGoogle Scholar
  2. 2.
    Helgeson VS, Siminerio L, Escobar O, Becker D. Predictors of metabolic control among adolescents with diabetes: A 4-year longitudinal study. J Pediatr Psychol. 2009; 34: 254–270.PubMedCrossRefGoogle Scholar
  3. 3.
    Seiffge-Krenke I, Stemmler M. Coping with everyday stress and links to medical and psychosocial adaptation in diabetic adolescents. J Adolesc Heal. 2003; 33: 180–188.CrossRefGoogle Scholar
  4. 4.
    Menzin J, Langley-Hawthorne C, Friedman M, Boulanger L, Cavanaugh R. Potential short-term economic benefits of improved glycemic control: A managed care perspective. Diabetes Care. 2001; 24: 51–55.PubMedCrossRefGoogle Scholar
  5. 5.
    Menzin J, Korn JR, Cohen J, et al. Relationship between glycemic control and diabetes-related hospital costs in patients with type 1 and type 2 diabetes mellitus. J Manag Care Pharm. 2010; 16: 264–275.PubMedGoogle Scholar
  6. 6.
    Grey M, Boland EA, Davidson M, Li J, Tamborlane WV. Coping skills training for youth with diabetes mellitus has long-lasting effects on metabolic control and quality of life. J Pediatr. 2000; 137: 107–113.PubMedCrossRefGoogle Scholar
  7. 7.
    Anderson BJ, Brackett J, Ho J, Laffel LM. An office-based intervention to maintain parent–adolescent teamwork in diabetes management. Impact on parent involvement, family conflict, and subsequent glycemic control. Diabetes Care. 1999; 22: 713–721PubMedCrossRefGoogle Scholar
  8. 8.
    Laffel LMB, Vangsness L, Connell A, et al.. Impact of ambulatory, family-focused teamwork intervention on glycemic control in youth with type 1 diabetes. J Pediatr. 2003; 142: 409–416.PubMedCrossRefGoogle Scholar
  9. 9.
    Nansel TR, Iannotti RJ, Simons-Morton BG, et al. Long-Term Maintenance of Treatment Outcomes: Diabetes Personal Trainer Intervention for Youth With Type 1 Diabetes. Diabetes Care. 2009; 32: 807–809.PubMedCrossRefGoogle Scholar
  10. 10.
    Channon SJ, Huws-Thomas MV, Rollnick S, et al. A multicenter randomized controlled trial of motivational interviewing in teenagers with diabetes. Diabetes Care. 2007; 30: 1390–1395.PubMedCrossRefGoogle Scholar
  11. 11.
    Svoren BM, Butler D, Levine BS, Anderson BJ, Laffel LM. Reducing acute adverse outcomes in youths with type 1 diabetes: A randomized, controlled trial. Pediatrics. 2003; 112: 914–922.PubMedCrossRefGoogle Scholar
  12. 12.
    Delamater AM, Jacobson AM, Anderson B, et al. Psychosocial therapies in diabetes: Report of the psychosocial therapies working group. Diabetes Care. 2001; 24: 1286–1292.PubMedCrossRefGoogle Scholar
  13. 13.
    Wysocki T, Harris MA, Buckloh LM, et al. Effects of behavioral family systems therapy for diabetes on adolescents' family relationships, treatment adherence, and metabolic control. J Pediatr Psychol. 2006; 31: 928–938.PubMedCrossRefGoogle Scholar
  14. 14.
    Wysocki T, Harris MA, Buckloh LM, et al. Randomized trial of behavioral family systems therapy for diabetes: Maintenance of effects on diabetes outcomes in adolescents. Diabetes Care. 2007; 30: 555–560.PubMedCrossRefGoogle Scholar
  15. 15.
    Urbach SL, LaFranchi S, Lambert L, et al. Predictors of glucose control in children and adolescents with type 1 diabetes mellitus. Pediatr Diabetes. 2005; 6: 69–74.PubMedCrossRefGoogle Scholar
  16. 16.
    Tershakovec AM, Kuppler K. Ethnicity, insurance type, and follow-up in a pediatric weight management program. Obes Res. 2003; 11: 17–20.PubMedCrossRefGoogle Scholar
  17. 17.
    Henggeler SW. Efficacy studies to large-scale transport: The development and validation of multisystemic therapy programs. Ann Rev Clin Psychol. 2011; 7: 351–81.PubMedCrossRefGoogle Scholar
  18. 18.
    Naar-King S, Podolski CL, Ellis DA, Frey MA. Social ecological model of illness management in high risk youth with type 1 diabetes. J Consult Clin Psychol. 2006; 74: 785–789.PubMedCrossRefGoogle Scholar
  19. 19.
    Ellis DA, Templin T, Naar-King S, et al. Multisystemic therapy for adolescents with poorly controlled type I diabetes: Stability of treatment effects in a randomized controlled trial. J Consult Clin Psychol. 2007; 75: 168–174.PubMedCrossRefGoogle Scholar
  20. 20.
    Ellis DA, Frey MA, Naar-King S, et al. The effects of multisystemic therapy on diabetes stress in adolescents with chronically poorly controlled type I diabetes: Findings from a randomized controlled trial. Pediatrics. 2005; 116: e826–e832.PubMedCrossRefGoogle Scholar
  21. 21.
    Ellis DA, Yopp J, Templin T, et al. Family mediators and moderators of treatment outcomes among youths with poorly controlled type 1 diabetes: Results from a randomized controlled trial. J Pediatr Psychol. 2007; 32: 194–205.PubMedCrossRefGoogle Scholar
  22. 22.
    Silverstein J, Klingensmith G, Copeland K, et al. (2005). Care of children and adolescents with type 1 diabetes: a statement of the American Diabetes Association. Diabetes Care. 2005; 28: 186–212.CrossRefGoogle Scholar
  23. 23.
    Henggeler SW, Schoenwald SK, Borduin CM: Multisystemic therapy for antisocial behavior in children and adolescents (second edition). New York: The Guilford Press, 2009.Google Scholar
  24. 24.
    Ellis DA, Frey MA, Naar-King S, et al. Use of multisystemic therapy to improve regimen adherence among adolescents with type 1 diabetes in chronic poor metabolic control: A randomized controlled trial. Diabetes Care. 2005; 28: 1604–1610.PubMedCrossRefGoogle Scholar
  25. 25.
    Ellis DA, Naar-King S, Cunningham PB, Secord E. Use of multisystemic therapy to improve antiretroviral adherence and health outcomes in HIV-infected pediatric patients: Evaluation of a pilot program. AIDS Patient Care STDs. 2006; 20: 112–121.PubMedCrossRefGoogle Scholar
  26. 26.
    Naar-King S, Ellis D, Kolmodin K, Cunningham P, Secord E. Feasibility of adapting multisystemic therapy to improve illness management behaviors and reduce asthma morbidity in high risk African American youth: A case series. J Child Fam Stud. 2009; 18: 564–573.CrossRefGoogle Scholar
  27. 27.
    Henggeler SW, Halliday-Boykins CA, Cunningham PB, et al. Juvenile drug court: Enhancing outcomes by integrating evidence-based treatments. J Consult Clin Psychol. 2006; 74: 42.PubMedCrossRefGoogle Scholar
  28. 28.
    Ellis DA, Naar-King S, Templin T, Frey MA, Cunningham PB. Improving health outcomes among youth with poorly controlled type 1 diabetes: The role of treatment fidelity in a randomized clinical trial of multisystemic therapy. J Fam Psychol. 2007; 21: 363–371.PubMedCrossRefGoogle Scholar
  29. 29.
    Safer DL, Hugo EM. Designing a control for a behavioral group therapy. Behav Ther. 2006; 37: 120–130.PubMedCrossRefGoogle Scholar
  30. 30.
    Frey MA, Ellis DA, Naar-King S, Greger N. Diabetes management of adolescents in poor metabolic control. Diabetes Educ. 2004; 30: 647–657.PubMedCrossRefGoogle Scholar
  31. 31.
    Frey MA, Denyes MJ. Health and illness self-care in adolescents with IDDM: A test of Orem's theory. Adv Nurs Sci. 1989; 12: 67–75.Google Scholar
  32. 32.
    Schilling LS, Grey M, Knafl K: A review of measures of self-management of type 1 diabetes by youth and their parents. Diabetes Educ. 2002; 28: 796–808.PubMedCrossRefGoogle Scholar
  33. 33.
    Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Research Group. Retinopathy and nephropathy in patients with type 1 diabetes four years after a trial of intensive therapy. N Engl J Med. 2000, 342: 381–389.CrossRefGoogle Scholar
  34. 34.
    White NH, Cleary PA, Dahms W, Goldstein D, Malone J, Tamborlane WV, Diabetes Control and Complications Trial (DCCT)/Epidemiology of Diabetes Interventions and Complications (EDIC) Research Group (2001) Beneficial effects of intensive therapy of diabetes during adolescence: Outcomes after the conclusion of the Diabetes Control and Complications Trial (DCCT). J Pediatr 139: 804–812.CrossRefGoogle Scholar
  35. 35.
    Nunn E, King B, Smart C, Anderson D. A randomized controlled trial of telephone calls to young patients with poorly controlled type 1 diabetes. Pediatr Diabetes. 2006; 7: 254–259.PubMedCrossRefGoogle Scholar
  36. 36.
    Martin CL, Albers J, Herman WH, et al. Neuropathy among the diabetes control and complications trial cohort 8 years after trial completion. Diabetes Care. 2006; 29: 340–344.PubMedCrossRefGoogle Scholar
  37. 37.
    Ellis D, Naar-King S, Templin T, et al. Multisystemic therapy for adolescents with poorly controlled type 1 diabetes: Reduced diabetic ketoacidosis admissions and related costs over 24 months. Diabetes Care. 2008; 31: 1746–1747.PubMedCrossRefGoogle Scholar

Copyright information

© The Society of Behavioral Medicine 2012

Authors and Affiliations

  • Deborah A. Ellis
    • 1
    • 3
  • Sylvie Naar-King
    • 1
  • Xinguang Chen
    • 1
  • Kathleen Moltz
    • 1
  • Phillippe B. Cunningham
    • 2
  • April Idalski-Carcone
    • 1
  1. 1.Carman and Ann Adams Department of PediatricsWayne State UniversityDetroitUSA
  2. 2.Department of PsychiatryMedical University of South CarolinaCharlestonUSA
  3. 3.Pediatric Prevention Research CenterOld Hutzel Hospital W534DetroitUSA

Personalised recommendations